Jennifer’s Journey is Far-Reaching
The story of Jennifer Cordts’ (right in photo) difficult diagnosis of Inflammatory Breast Cancer (IBC) has garnered worldwide attention. And for good reason. Jennifer is determined to educate the public about this rare form of the disease that so few people know anything about.
The sister of one of GHB’s long-time insurance carrier representatives Suzanne Pitone (left in photo) of Principal Financial, Jennifer expressed her desire to increase awareness of IBC on a blog she wrote for GHB in October 2016 for Breast Cancer Awareness month.
Last spring, WFAA-TV in Texas did an amazingly open and honest interview with Jennifer that resulted in “Jennifer’s Journey” that aired last May. Since that time, the story has been covered by Self.com, The Daily Mail, Redbook Magazine, MSN.com and scores of other blogs and media outlets, reaching millions of people throughout the U.S. and abroad…and saving lives.
Jennifer’s Journey is Recognized
Now, Jennifer has more great news about “Jennifer’s Journey.” She writes:
“When I agreed to an interview with Channel 8 news, I had no idea what I was going to say to them. This would be the first time that I would share publicly my diagnosis of Inflammatory Breast Cancer. Soon after the news crew arrived, the words and tears seemed to flow on their own. It was raw and emotional and the three of us shared awkward moments of silence while we re-grouped and composed ourselves. Jason Whitely, Channel 8 reporter and Brandon Mowry, Channel 8 Photojournalist, were here for several hours that day. Since then, “Jennifer’s Journey” has spread like wildfire worldwide, raising awareness for Inflammatory Breast Cancer.
These two men walked into my home as strangers and left unsung heroes.
Congratulations Jason Whitely and Brandon Mowry, I cannot think of a more deserving duo. Thank you for your professionalism, tenderness, talent and friendship–thanks to you lives are being saved.”
Learn more or donate to IBC research in Jennifer Cordts’ name at the Inflammatory Breast Cancer Research Foundation.